JPH0582192B2 - - Google Patents
Info
- Publication number
- JPH0582192B2 JPH0582192B2 JP1922586A JP1922586A JPH0582192B2 JP H0582192 B2 JPH0582192 B2 JP H0582192B2 JP 1922586 A JP1922586 A JP 1922586A JP 1922586 A JP1922586 A JP 1922586A JP H0582192 B2 JPH0582192 B2 JP H0582192B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- virus
- porcine parvovirus
- cultured
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000283690 Bos taurus Species 0.000 claims description 20
- 230000002238 attenuated effect Effects 0.000 claims description 20
- 210000004927 skin cell Anatomy 0.000 claims description 15
- 241000282898 Sus scrofa Species 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 241000125945 Protoparvovirus Species 0.000 claims description 3
- 241000702619 Porcine parvovirus Species 0.000 description 33
- 241000700605 Viruses Species 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 26
- 241000282887 Suidae Species 0.000 description 18
- 210000004748 cultured cell Anatomy 0.000 description 8
- 229960005486 vaccine Drugs 0.000 description 7
- 239000006285 cell suspension Substances 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 5
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 208000008071 Parvoviridae Infections Diseases 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000002255 vaccination Methods 0.000 description 3
- 230000005727 virus proliferation Effects 0.000 description 3
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010057343 Parvovirus infection Diseases 0.000 description 2
- 206010058874 Viraemia Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000012888 bovine serum Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000000120 cytopathologic effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- FXKZPKBFTQUJBA-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;sodium;dihydrate Chemical compound O.O.[Na].[Na].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O FXKZPKBFTQUJBA-UHFFFAOYSA-N 0.000 description 1
- 241000710777 Classical swine fever virus Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1922586A JPS62179385A (ja) | 1986-01-31 | 1986-01-31 | 豚パルボウイルスの弱毒株の作出法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1922586A JPS62179385A (ja) | 1986-01-31 | 1986-01-31 | 豚パルボウイルスの弱毒株の作出法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62179385A JPS62179385A (ja) | 1987-08-06 |
| JPH0582192B2 true JPH0582192B2 (enrdf_load_stackoverflow) | 1993-11-17 |
Family
ID=11993429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1922586A Granted JPS62179385A (ja) | 1986-01-31 | 1986-01-31 | 豚パルボウイルスの弱毒株の作出法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62179385A (enrdf_load_stackoverflow) |
-
1986
- 1986-01-31 JP JP1922586A patent/JPS62179385A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62179385A (ja) | 1987-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5597721A (en) | Preparation of antigens of and of vaccines for the virus of mystery disease, antigens and vaccines obtained for the prevention of this disease | |
| CN107746832B (zh) | 一株高滴度的柯萨奇病毒a10驯化株及其应用 | |
| JPH07289250A (ja) | ブタ生殖呼吸症候群ウイルス（ｐｒｒｓｖ）のヨーロッパワクチン株 | |
| JPH0157954B2 (enrdf_load_stackoverflow) | ||
| CN107739731B (zh) | 包含柯萨奇病毒a10驯化株的病毒组合物及其应用 | |
| US3959466A (en) | Highly attenuated cytomegalovirus vaccine and production thereof | |
| BR112013017171B1 (pt) | composição combinada heptavalente estável | |
| US3520972A (en) | Feline virus vaccines obtained by propagation and serial passage attenuation of virulent feline viruses in diploid feline embryo tissue cell serial passage subculture strains | |
| JP2751950B2 (ja) | 増殖肝炎ａ型ウイルス | |
| CN111849924B (zh) | 类nadc30猪蓝耳病强毒株、弱毒株及其应用 | |
| ES2560452T3 (es) | Vacuna de IPV-DPT | |
| KR100531491B1 (ko) | 백신으로서 소 호흡 코로나바이러스 | |
| CN103923885B (zh) | 鸡传染性法氏囊病毒Vero细胞适应株及其应用 | |
| CN106310250A (zh) | 一种猪瘟口服弱毒冻干疫苗、其制备方法及冻干保护剂 | |
| US3156620A (en) | Attenuated live rabies vaccine and method of preparing the same | |
| US5021348A (en) | Attenuated hepatitis A virus | |
| US2965544A (en) | Tissue culture propagated canine distemper virus and vaccine thereof | |
| JPH0582192B2 (enrdf_load_stackoverflow) | ||
| CN1306961C (zh) | 四价轮状病毒灭活疫苗的制备及应用 | |
| CN100528227C (zh) | 乙型脑炎病毒疫苗及其制备方法 | |
| CN104031888B (zh) | 鸡新城疫病毒弱毒株、灭活疫苗及其应用 | |
| EP0562136A1 (en) | Live vaccine to getah virus infectious disease, and trivalent live vaccine to Japanese encephalitis virus, porcine parvovirus and getah virus infectious diseases | |
| El‐Zein et al. | Preparation and testing of a goat pox vaccine from a pathogenic field isolate attenuated in cell culture | |
| US5514376A (en) | Cell culture of hepatitis A virus | |
| CN119258207A (zh) | 高致病性猪繁殖与呼吸综合征耐热保护剂活疫苗 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |